A radioimmunoassay for VP16-213 in plasma.
A radioimmunoassay for the semi-synthetic podophyllotoxin VP16-213 has been developed which is suitable for pharmacokinetic studies of the drug. A high titre antiserum was produced in a sheep in response to a VP16-213-BSA conjugate prepared using sodium periodate. Podophyllotoxin does not cross-react with the antiserum and VM26 cross-reacts to only a small extent (less than 0.6%). In the absence of a high specific activity tritium label, a radioiodinated histamine ligand was produced which was only partially displaced from antibody by native drug. VP16-213 can be measured in plasma without prior drug extraction with a theoretical limit of detection of 5-10 micrograms/l. VP16-213 cis (picro) hydroxy acid is recognised by the antiserum to a greater extent than the drug itself. Thus, in order to eliminate any interference from the trans hydroxy acid metabolite chloroform extraction of plasma samples was carried out.
D000818:Animals; D055598:Chemical Phenomena; D002621:Chemistry; D003429:Cross Reactions; D005047:Etoposide / Q000097:blood*; D006632:Histamine; D006801:Humans; D011034:Podophyllotoxin / Q000031:analogs & derivatives*; D011863:Radioimmunoassay / Q000379:methods; D012756:Sheep / Q000276:immunology
D005047:Etoposide; D006632:Histamine; D011034:Podophyllotoxin